Journal profile · ENDOCRINOLOGY & METABOLISM

Current Diabetes Reviews

ISSN 1573-3998 · eISSN 1875-6417 · Bentham

Current Diabetes Reviews: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; median 110 days to acceptance (38 articles, last 24 months); 40 articles in 2025; indexed in ESCI and Scopus.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
CiteScore quartileQ2Endocrinology, Diabetes and Metabolism · rank 96/250
Review time110 daysMedian, submission to acceptance · 38 articles, last 24 months · Crossref
APC—No source gives fee information
Acceptance—No reports yet
Articles per year402025 · OpenAlex count

Scope

Aims, scope and focus

Current Diabetes Reviews is published by Bentham and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes Treatment and Management and Diabetes, Cardiovascular Risks, and Lipoproteins, together about 42% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): ENDOCRINOLOGY & METABOLISM

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Diabetes Management and ResearchMedicine17.3%
  2. Diabetes Treatment and ManagementMedicine13.6%
  3. Diabetes, Cardiovascular Risks, and LipoproteinsMedicine11.1%
  4. Diabetes Management and EducationMedicine7.8%
  5. Pancreatic function and diabetesMedicine4.9%
  6. Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.4%
  7. Natural Antidiabetic Agents StudiesMedicine4.2%
  8. Adipokines, Inflammation, and Metabolic DiseasesMedicine3.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorEndocrinology & MetabolismZone 4

Top journal: noReview journal: yes

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorEndocrinology & MetabolismZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
Endocrinology, Diabetes and MetabolismQ296/250—
EndocrinologyQ262/132—

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
5.4LetPub ·
SJR 2026-06
0.66LetPub ·
SNIP 2026-06
0.88LetPub ·
h-index
86OpenAlex ·
i10-index
768OpenAlex ·
2-year mean citedness
3.3OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
7.54%LetPub ·

Volume

Articles per year
38LetPub ·

Articles by year OpenAlex count · 1,506 in total · the current year is incomplete

YearArticlesOpen accessCitations
202653272,221
202540373,658
2024117273,959
2023108143,636
202211963,546
2021121123,008

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

110 daysMedian, submission to acceptance · P25–P75 84 days – 128 days

Acceptance to online
median 311 days (38 articles)
Submission to online
median 412 days
Sample
38 articles with submission and acceptance dates (215 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Bentham
ISSN
1573-3998
Electronic ISSN
1875-6417
Official links

FAQ

Frequently asked questions about Current Diabetes Reviews

What CAS zone is Current Diabetes Reviews in?

In the 2025 upgraded edition of the CAS Journal Ranking, Current Diabetes Reviews is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Current Diabetes Reviews?

Based on the dates recorded on 38 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 110 days (interquartile range 84–128 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Current Diabetes Reviews?

According to LetPub and DOAJ records, Current Diabetes Reviews is indexed in ESCI and Scopus.

Is Current Diabetes Reviews open access, and what is the APC?

Current Diabetes Reviews is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .